Supply Chain and Logistics for Cell Therapies Summit
Other Event Ended
Share Event
https://go.evvnt.com/805205-0?pid=5563
At the virtual 2nd Supply Chain and Logistics for Cell Therapies Summit, your community will gather to network, share exclusive insights in case-study led sessions, and propose best practice for seamless vein-to-vein delivery at the clinical and commercial scale.
Implement robust, patient-centric supply chains for clinical to commercial readiness:
- Build your supply strategy and manage risk and forecasting at scale by designing for growth
- Maximize your cloud-based and integrated systems and hear the latest innovations in chain of identity
- Manage materials, external manufacturing and facility design
Optimize patient care with best practice guidelines and integrated platforms:
- Understand clinical requirements and develop clinical strategies for seamless therapeutic delivery:
- Discuss and establish industry best practices and understand which standard practices can apply across a range of cell modalities
Maintain product quality at scale for seamless delivery of autologous and allogeneic therapies:
- Optimize front-end processes and develop patient care organisations
- Discuss quality control and site audits to ensure best standard of care and product quality
Where
When
26 Oct 2021,
Tuesday,
09:00 AM [America/St_Thomas time]
Till
28 Oct 2021,
Thursday
,
05:30 PM [America/St_Thomas time]
See events date
Event Info
URLs:
Tickets: https://go.evvnt.com/805205-2?pid=5563
Brochure: https://go.evvnt.com/805205-3?pid=5563
Prices:
Digital Attendance - Drug Developer - Conference + 2 Workshops: USD 2897.0,
Digital Attendance - Drug Developer - Conference Only: USD 2099.0,
Digital Attendance - Standard - Conference + 2 Workshops: USD 3997.0,
Digital Attendance - Standard - Conference Only: USD 3099.0,
Digital Attendance - Academic - Conference + 2 Workshops: USD 2497.0,
Digital Attendance - Academic - Conference Only: USD 1899.0
Speakers: Beth Gardner, Senior Director Patient Supply US, bluebird bio, Cindy McNab, Supply Chain Director, Allogene Therapeutics, Craig Beasley, VP Supply Chain, Cell Therapy, Bristol Myers Squibb, William Shingler, Senior Director, Patient and Cell Management, Autolus Ltd, Alicia Dixon, Senior Director Cell Therapy Patient Services, Gamida Cell, David Lewandowski, Global Business Development Manager, Cryo Division, Brooks Life Sciences, Kenneth Locke, VP Manufacturing, Carisma Therapeutics, Peter Olagunju, SVP Technical Operations, FerGene, Christopher Baldwin, Supply Chain Director, Cell Therapy, GSK, Delfi Krishna, Head of Strategic Operations Cell and Gene Therapy, Immatics, Karen Moniz, Technical Director, ICCBBA, Lizette Caballero, CAR-T Apheresis Site Liaison, The Janssen Pharmaceutical Companies of Johnson and Johnson, Albert Ribickas, Supervisor, Cell Therapy Facility, Moffitt Cancer Center, Blair Grimes, Clinical Supply Chain Manager, Precision BioSciences, Mary Sell, CAR-T Cell Collection Operations Senior Manager, Janssen Pharmaceutical, Stephen Chen, COO, NKGen Biotech, Bob Amareld, Head of Supply Chain, Precision Biosciences, Ryan Phillips, Strategic Sourcing Manager, Precision BioSciences, Sebastian Schneider, Strategy Lead Cell and Gene Therapy Industrialization, Roche, Tour Ala, IT Lead for Cell and Gene Therapy Industrialization, Roche, Daniel Bright, Director Manufacturing Operations, Cellectis, Robert Shaw, Executive Director, Standards Coordinating Body, Stephanie Mgebroff, Director Research Quality Control, Seattle Children's Research Institute, Tyson Fetzer, Head of Supply Chain, Rubius Therapeutics, Devin Blass, VP Technical Operations, Talaris Therapeutics, Lan Bui, Director Cell Therapies Supply Chain, Takeda, Nicole Rickard, Head of Supply Chain, Cell and Gene Therapies, Vertex Pharmaceuticals
Category: Conferences | Science, Health and Medicine